Mumbai company gets approval for clinical trial of drug on coronavirus patients
Glenmark said it has received approval for conducting the trial on mild to moderate patients
Another Bangalore company has also applied to start clinical trials
Mumbai-based Glenmark Pharmaceuticals today said has received approval from the Drug Controller General of India to conduct clinical trials of antiviral drug favipiravir on coronavirus patients. The product is a generic version of Avigan of Fujifilm Toyama Chemical Co. Ltd., Japan. This news sent Glenmark shares as much as 9% higher today.